CHLOE EQ’s automated capabilities provide embryologists with previously unachievable data

Prestigious international annual awards programme recognises CHLOE EQ for bringing transparency to IVF process

CRGH Insight will utilise Fairtility’s explainable AI for embryo quality analysis, offering transparency to IVF professionals and patients

The femtech market is expected to reach US$50bn by 2025, but health inequalities remain. In our first FemTech World x HealthTech World roundtable, five leading experts...

The findings were revealed ahead of the American Society of Reproductive Medicine’s Scientific Congress

The sessions will be taught by experts in AI, fertility, clinical research, digital health and patient care

CHLOE EQ™ is the first AI-powered tool for embryo classification and selection to achieve CE MDR approval

The company will share clinical data on the effectiveness of its AI-powered embryo quality assessment assistant

The Israeli fertility company brings the total funding to US$18.5m to date